Redemption in Elekta AB (SE) — SEK 311.5 million Healthcare Redemption in Elekta AB (SE) — SEK 311.5 million
Divestment of AB Previa (SE) to Tryg i Danmark smba (DK) by Segulah (SE) — Amount not disclosed. Healthcare Divestment of AB Previa (SE) to Tryg i Danmark smba (DK) by Segulah (SE) — Amount not disclosed.
Rights issue in Swedish Orphan Biovitrum (SE) — SEK 637 million Healthcare Rights issue in Swedish Orphan Biovitrum (SE) — SEK 637 million
Rights issue in PA Resources (SE) — SEK 891 million Oil & Gas Rights issue in PA Resources (SE) — SEK 891 million
Secondary placing of 19.5 million shares in Fabege (SE) — SEK 663 million Real Estate Secondary placing of 19.5 million shares in Fabege (SE) — SEK 663 million
Divestment of If (SE) shareholding by Skandia Liv (SE) to Sampo (FI) — SEK 2.4 billion FIG Divestment of If (SE) shareholding by Skandia Liv (SE) to Sampo (FI) — SEK 2.4 billion
Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million Healthcare Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million
Initial public offering of Capio AB (SE) — Market value approx. SEK 2.95 billion Healthcare Initial public offering of Capio AB (SE) — Market value approx. SEK 2.95 billion
Divestment of Swedish Orphan International AB (SE) to Investor Growth Capital (SE) and Skandia Investment (SE) — Amount not disclosed. Healthcare Divestment of Swedish Orphan International AB (SE) to Investor Growth Capital (SE) and Skandia Investment (SE) — Amount not disclosed.
New share issue in Biotage AB (SE) — SEK 97 million Healthcare New share issue in Biotage AB (SE) — SEK 97 million
Directed new share issue in BioInvent International (SE) — SEK 136 million Healthcare Directed new share issue in BioInvent International (SE) — SEK 136 million
Divestment of Telia’s (SE) commercial property portfolio — SEK 5.1 billion Real Estate Divestment of Telia’s (SE) commercial property portfolio — SEK 5.1 billion